Navigation Links
Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
Date:3/13/2009

Preclinical Rationale for Clinical Trial Presented at USCAP Meeting

SOUTH SAN FRANCISCO, Calif., March 13 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the enrollment of the first patient in a Phase 2, multi-center clinical trial of R788 (fostamatinib disodium) in patients with refractory or relapsed peripheral T-cell lymphoma (PTCL). The clinical trial's primary objective is to assess the efficacy of R788, an orally bio-available Syk kinase inhibitor, in patients suffering from this subset of non-Hodgkin's lymphoma that originates in the patient's T-cells. Prior studies have suggested increased expression of Syk at the cellular level in many of these patients with PTCL.

"Since we have seen that R788 shows clinical therapeutic benefit in certain types of B-cell lymphomas and that Syk kinase appears to play an important role in certain PTCLs, we believe that R788 may offer new hope to the 12-15% of non-Hodgkin's lymphoma patients with the T-cell variety," said Elliott Grossbard, M.D., executive vice president and chief medical officer of Rigel.

In general, patients with PTCL have a poorer prognosis and fewer treatment options than B-cell lymphoma patients. The standard treatment regimen for PTCL, known as CHOP, fails to provide adequate or durable responses in many patients. CHOP is a treatment regimen consisting of cyclophosphamide, hydroxydoxorubicin, vincristine (oncovin) and prednisone.

Pre-clinical Results Presented at USCAP Meeting

In a related matter, results of a pre-clinical study of R788 were presented in an oral session of the United States and Canadian Academy of Pathology annual meeting in Boston this week on March 9, 2009. The presentation, entitled, "An Orally Available Syk Tyrosine Kinase Inhibitor Induces Apoptosis
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
2. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
3. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
4. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
6. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
7. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
8. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
9. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
10. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
11. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015  Bayer Corporation hosted its annual ... at the Bayer HealthCare US headquarters.  This is Bayer,s second ... Whippany campus, and Thursday,s event welcomed ... every day at work. Fortunately, for the kids, ... a company whose mission is "Science For A Better Life," ...
(Date:4/24/2015)... HILL, N.C. , April 24, 2015 /PRNewswire/ ... the ability of consumers to educate themselves about ... expanded the tools and techniques available to market ... Given the changing consumer marketplace, it,s imperative that ... approaches to better identify market opportunities, niches and ...
(Date:4/24/2015)...  Span-America Medical Systems, Inc. (NASDAQ:  SPAN) announced ... second quarter results on Thursday, April 30, after the ... will conduct a conference call at 10:00 a.m. ... financial and operating results for the second quarter ended ... conference call will be available online at ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2
(Date:4/26/2015)... (PRWEB) April 26, 2015 Italian public ... deadly legacy of asbestos cement plants and other asbestos-related ... the new research. Click here to read it ... Italy’s Department of Occupational and Environmental Medicine analyzed more ... and found 32 clusters where the asbestos cancer was ...
(Date:4/26/2015)... A live auction will be held to ... surgery centers and other medical facilities around the United ... radiology, surgery, endoscopy, lab, anesthesia, exam and much more. ... April 28th starting at 10:00am EDT. The equipment is ... Hiatus Rd., Sunrise, FL 33351. Anyone can participate ...
(Date:4/26/2015)... Hartford, CT (PRWEB) April 26, 2015 The ... welcome and reflection by Deb Dettor, CCAR’s Managing Director. Deb ... Phil Valentine who was not in attendance because of his ... To everyone’s delight, Phil was able to express his gratitude ... thanked the volunteers for their dedication to carrying out CCAR’s ...
(Date:4/25/2015)... Washington, D.C. (PRWEB) April 25, 2015 ... supporters worldwide will join The Million Nets Pledge, a ... Nets campaign to protect refugee families with one million ... on their increased work with UN partners to protect ... Africa from malaria. , “There has been a ...
(Date:4/25/2015)... By definition, a CIO’s responsibility is to support the ... their judgement and expertise to keep digital assets and environments ... article published in National Mortgage News on April 22nd, 2015 ... to their responsibilities by focusing too heavily on making sure ... it comes to company policy and industry best practices, and ...
Breaking Medicine News(10 mins):Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:The Connecticut Community for Addiction Recovery (CCAR) honors its volunteers during National Volunteer Recognition Week. 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5
... the rise among patients who suffer from acute illness. The ... of Hygiene and Tropical Medicine, //said that they wanted to ... ,The Lancet studied and analyzed the 3 million ... 3,755 a clot on the lung. The London team found ...
... relief FDA, the U.S. health regulators, gave their nod to ... organ rejection in heart transplant patients.// ,The drug, Astellas ... liver and kidney transplants. ,Dr. Steven Galson, head ... "The doctors who perform approximately 2,200 heart transplants in the ...
... In a news study it has been shown that babies ... not have the much feared consequences and is safe. The ... ,The theory was researched and assessed by unconnected Nottingham researchers ... method was pioneered by controversial Stoke-based paediatrician Professor David Southall. ...
... to a village in Bihar was left for herself to cremate ... nobody turned up// give a helping hand. The widow dragged his ... rites herself. ,Grief-stricken Dhanua Devi (named changed), a 36-year-old resident ... visited her thatched hut to console her. ,A mother ...
... to the tune of ?4m or more will be allocated ... spending should take care of containing// the unhealthy trend, atleast ... up by almost 50%. ,A senior medical post ... with suicidal tendencies, according to Mr Woodward. To enable this ...
... dismissed increased risk of heart attack associated with Vioxx, has ... 'out of the mainstream' as it is based on biased ... ,Thomas Cona and John Mcdarby have sued the ... in heart attacks. More than 10, 000 different lawsuits has ...
Cached Medicine News:Health News:DVT Risk Increased After Acute Infections 2Health News:Doctor Grilled In Court For False Report About Vioxx Health Risk 2
... for destruction and removal of pathological fabrics ... the field of a cerebrum brain, spinal ... zone in a consequence of a working ... interaction arises cavitational processes. They promote destruction ...
... Dissectron ultrasonic aspirator, ... ultrasonic surgical aspirator for ... of tissue available only ... Gathers in a very ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Medicine Products: